Inactive Instrument

News Idenix Pharmaceuticals Inc

Equities

US45166R2040

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	AbbVie : Merck says hepatitis C drugs to lose breakthrough status	RE
2014	Apple : Wall St. edges up, lifted by mergers, acquisitions	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AbbVie : Merck says hepatitis C drugs to lose breakthrough status	15-02-04	RE
Apple : Wall St. edges up, lifted by mergers, acquisitions	14-06-10	RE
Idenix Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Idenix Pharmaceuticals Inc.	14-06-10	PR
Apple : U.S. futures dip, S&P 500 comes off fourth straight record	14-06-10	RE
Bank of America : Dow, S&P 500 extend string of record closes; VIX up	14-06-09	RE
Idenix Pharmaceuticals : Clinical Test Results, Improved Medical Care, and Rejection of Buyout Proposal by Medical Companies - Analyst Notes on AstraZeneca, LifePoint, Insmed, Dendreon and Idenix Pharmaceuticals	14-05-23	PR
Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case	14-03-24	GL
Idenix Pharmaceuticals Inc : Files Patent Infringement Lawsuits Against Gilead Sciences in Europe	14-03-14	GL
Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Patent Interference	14-01-29	GL
Idenix to Raise $106.7 Million Through Registered Direct Offering	14-01-28	GL
Idenix Pharmaceuticals Inc : Price Movements, Leadership Appointments, Patient Enrollments and Supply Agreements - Research Report on Santarus, Hologic, Brookdale, Idenix, and Biodel	13-12-20	PR
Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Announces Declaration of Senior Party in a Second Patent Interference by the USPTO	13-12-09	PU
Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals to Present at Two Upcoming Healthcare Conferences	13-11-25	PU
Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2013 Financial Results and Provides HCV Pipeline Update	13-10-30	PU
Idenix Pharmaceuticals Inc : Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2013 Financial Results and HCV Pipeline Update on Wednesday, October 30, 2013	13-10-28	PU
Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Announces Nucleotide Prodrug Program Poster Presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting	13-10-01	PU
Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Reports Second Quarter and Six Month 2013 Financial Results	13-08-07	PU
Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals, Inc. to Hold Second Quarter and Six Month 2013 Financial Results Conference Call on Wednesday, August 7, 2013	13-08-06	PU
Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals Announces Update on Development Program for Its Lead HCV Nucleotide Prodrug Candidate, IDX20963	13-06-20	PU
Idenix Pharmaceuticals Inc : Idenix Pharmaceuticals to Present at the Wells Fargo Securities 2013 Healthcare Conference	13-06-11	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Idenix Pharmaceuticals Inc

Equities

US45166R2040

Summary

Filters